Cargando…

Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial

BACKGROUND: The objective of this report is to describe the methods used to develop and validate a computerized system to analyze Humphrey visual fields obtained from patients with non-arteritic anterior ischemic optic neuropathy (NAION) and enrolled in the Ischemic Optic Neuropathy Decompression Tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Feldon, Steven E, Levin, Lori, Scherer, Roberta W, Arnold, Anthony, Chung, Sophia M, Johnson, Lenworth N, Kosmorsky, Gregory, Newman, Steven A, Katz, Joanne, Langenberg, Patricia, Wilson, P David, Kelman, Shalom E, Dickersin, Kay
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1685661/
https://www.ncbi.nlm.nih.gov/pubmed/17116264
http://dx.doi.org/10.1186/1471-2415-6-34
_version_ 1782131179387879424
author Feldon, Steven E
Levin, Lori
Scherer, Roberta W
Arnold, Anthony
Chung, Sophia M
Johnson, Lenworth N
Kosmorsky, Gregory
Newman, Steven A
Katz, Joanne
Langenberg, Patricia
Wilson, P David
Kelman, Shalom E
Dickersin, Kay
author_facet Feldon, Steven E
Levin, Lori
Scherer, Roberta W
Arnold, Anthony
Chung, Sophia M
Johnson, Lenworth N
Kosmorsky, Gregory
Newman, Steven A
Katz, Joanne
Langenberg, Patricia
Wilson, P David
Kelman, Shalom E
Dickersin, Kay
author_sort Feldon, Steven E
collection PubMed
description BACKGROUND: The objective of this report is to describe the methods used to develop and validate a computerized system to analyze Humphrey visual fields obtained from patients with non-arteritic anterior ischemic optic neuropathy (NAION) and enrolled in the Ischemic Optic Neuropathy Decompression Trial (IONDT). The IONDT was a multicenter study that included randomized and non-randomized patients with newly diagnosed NAION in the study eye. At baseline, randomized eyes had visual acuity of 20/64 or worse and non-randomized eyes had visual acuity of better than 20/64 or were associated with patients refusing randomization. Visual fields were measured before treatment using the Humphrey Field Analyzer with the 24-2 program, foveal threshold, and size III stimulus. METHODS: We used visual fields from 189 non-IONDT eyes with NAION to develop the computerized classification system. Six neuro-ophthalmologists ("expert panel") described definitions for visual field patterns defects using 19 visual fields representing a range of pattern defect types. The expert panel then used 120 visual fields, classified using these definitions, to refine the rules, generating revised definitions for 13 visual field pattern defects and 3 levels of severity. These definitions were incorporated into a rule-based computerized classification system run on Excel(® )software. The computerized classification system was used to categorize visual field defects for an additional 95 NAION visual fields, and the expert panel was asked to independently classify the new fields and subsequently whether they agreed with the computer classification. To account for test variability over time, we derived an adjustment factor from the pooled short term fluctuation. We examined change in defects with and without adjustment in visual fields of study participants who demonstrated a visual acuity decrease within 30 days of NAION onset (progressive NAION). RESULTS: Despite an agreed upon set of rules, there was not good agreement among the expert panel when their independent visual classifications were compared. A majority did concur with the computer classification for 91 of 95 visual fields. Remaining classification discrepancies could not be resolved without modifying existing definitions. Without using the adjustment factor, visual fields of 63.6% (14/22) patients with progressive NAION and no central defect, and all (7/7) patients with a paracentral defect, worsened within 30 days of NAION onset. After applying the adjustment factor, the visual fields of the same patients with no initial central defect and 5/7 of the patients with a paracentral defect were seen to worsen. CONCLUSION: The IONDT developed a rule-based computerized system that consistently defines pattern and severity of visual fields of NAION patients for use in a research setting.
format Text
id pubmed-1685661
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-16856612006-12-11 Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial Feldon, Steven E Levin, Lori Scherer, Roberta W Arnold, Anthony Chung, Sophia M Johnson, Lenworth N Kosmorsky, Gregory Newman, Steven A Katz, Joanne Langenberg, Patricia Wilson, P David Kelman, Shalom E Dickersin, Kay BMC Ophthalmol Research Article BACKGROUND: The objective of this report is to describe the methods used to develop and validate a computerized system to analyze Humphrey visual fields obtained from patients with non-arteritic anterior ischemic optic neuropathy (NAION) and enrolled in the Ischemic Optic Neuropathy Decompression Trial (IONDT). The IONDT was a multicenter study that included randomized and non-randomized patients with newly diagnosed NAION in the study eye. At baseline, randomized eyes had visual acuity of 20/64 or worse and non-randomized eyes had visual acuity of better than 20/64 or were associated with patients refusing randomization. Visual fields were measured before treatment using the Humphrey Field Analyzer with the 24-2 program, foveal threshold, and size III stimulus. METHODS: We used visual fields from 189 non-IONDT eyes with NAION to develop the computerized classification system. Six neuro-ophthalmologists ("expert panel") described definitions for visual field patterns defects using 19 visual fields representing a range of pattern defect types. The expert panel then used 120 visual fields, classified using these definitions, to refine the rules, generating revised definitions for 13 visual field pattern defects and 3 levels of severity. These definitions were incorporated into a rule-based computerized classification system run on Excel(® )software. The computerized classification system was used to categorize visual field defects for an additional 95 NAION visual fields, and the expert panel was asked to independently classify the new fields and subsequently whether they agreed with the computer classification. To account for test variability over time, we derived an adjustment factor from the pooled short term fluctuation. We examined change in defects with and without adjustment in visual fields of study participants who demonstrated a visual acuity decrease within 30 days of NAION onset (progressive NAION). RESULTS: Despite an agreed upon set of rules, there was not good agreement among the expert panel when their independent visual classifications were compared. A majority did concur with the computer classification for 91 of 95 visual fields. Remaining classification discrepancies could not be resolved without modifying existing definitions. Without using the adjustment factor, visual fields of 63.6% (14/22) patients with progressive NAION and no central defect, and all (7/7) patients with a paracentral defect, worsened within 30 days of NAION onset. After applying the adjustment factor, the visual fields of the same patients with no initial central defect and 5/7 of the patients with a paracentral defect were seen to worsen. CONCLUSION: The IONDT developed a rule-based computerized system that consistently defines pattern and severity of visual fields of NAION patients for use in a research setting. BioMed Central 2006-11-20 /pmc/articles/PMC1685661/ /pubmed/17116264 http://dx.doi.org/10.1186/1471-2415-6-34 Text en Copyright © 2006 Feldon et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Feldon, Steven E
Levin, Lori
Scherer, Roberta W
Arnold, Anthony
Chung, Sophia M
Johnson, Lenworth N
Kosmorsky, Gregory
Newman, Steven A
Katz, Joanne
Langenberg, Patricia
Wilson, P David
Kelman, Shalom E
Dickersin, Kay
Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial
title Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial
title_full Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial
title_fullStr Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial
title_full_unstemmed Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial
title_short Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial
title_sort development and validation of a computerized expert system for evaluation of automated visual fields from the ischemic optic neuropathy decompression trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1685661/
https://www.ncbi.nlm.nih.gov/pubmed/17116264
http://dx.doi.org/10.1186/1471-2415-6-34
work_keys_str_mv AT feldonstevene developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial
AT levinlori developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial
AT schererrobertaw developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial
AT arnoldanthony developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial
AT chungsophiam developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial
AT johnsonlenworthn developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial
AT kosmorskygregory developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial
AT newmanstevena developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial
AT katzjoanne developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial
AT langenbergpatricia developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial
AT wilsonpdavid developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial
AT kelmanshalome developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial
AT dickersinkay developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial
AT developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial